KSM Feed

Delta reinfection risk low among unvaccinated children.

KSM study: Immunity against COVID-19 among children many months after infection.

Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents.

KSM partners with PrognomiQ to improve early cancer detection.

KSM’s unique collaboration with PrognomiQ advances cancer detection.

Globes: KSM launches Season 2 of its popular podcast.

KSM cooperation with Bahrein on prime time.

Our strategic agreement with Bahrain continues to make headlines.

KSM-Bahrain collaboration on research.

KSM signed an agreement for joint medical research with Bahrain.

Dr. Patalon sharing her insights on why we are afraid to cope with death.

Dr. Tal Patalon, head of KSM, hosts Dr. Nader Butto in her podcast.

Our new COVID-19 4th shot study continues to make headlines.

Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news.

The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses.